Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Gross Margin

Ampio Pharmaceuticals Gross Margin Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Gross Margin from 2011 to 2015. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Ampio Pharmaceuticals Gross Margin for the quarter ending December 12, 2015 was $48m a -108.43% decrease of -52m year over year
  • Ampio Pharmaceuticals Gross Margin for the last 12 months ending September 09, 2016 was $68m a 0.00% decrease of 0m year over year
  • Ampio Pharmaceuticals Annual Gross Margin for 2015 was $68m a -46.56% decrease of -32m from 2014
  • Ampio Pharmaceuticals Annual Gross Margin for 2014 was $100m a 0.00% decrease of 0m from 2013
  • Ampio Pharmaceuticals Annual Gross Margin for 2013 was $100m a 0.00% decrease of 0m from 2012
Other Margins & Efficiency Metrics:
  • Ampio Pharmaceuticals Return on Capital % for the quarter ending September 09, 2017 was -433.67 a 79.28% decrease of -343.82 year over year
  • Ampio Pharmaceuticals Return on Equity % for the quarter ending September 09, 2017 was -962.39 a 83.01% decrease of -798.83 year over year
View Chart On Koyfin

Quarterly AMPE Gross Margin Data

12/2015$48m
09/2015$92m
06/2015$52m
03/2015$100m
12/2014$100m
09/2014$100m
06/2014$100m
03/2014$100m
12/2013$100m
09/2013$100m

Annual AMPE Gross Margin Data

2015$68m
2014$100m
2013$100m
2012$100m
2011$100m